Meprobamate-d7
|
R122503-500μg
|
98% |
1435933-83-7 |
500μg
|
¥ 2427.0
|
5~7个工作日 |
罗恩 |
D-AP7
|
D344909-10mg
|
|
81338-23-0 |
10mg
|
¥ 2448.9
|
期货,请咨询 |
阿拉丁 |
cholesterol-d7
|
K028885-10mg
|
99% |
83199-47-7 |
10mg
|
¥ 1920.0
|
4~8周 |
科威 |
cholesterol-d7
|
K028885-25mg
|
99% |
83199-47-7 |
25mg
|
¥ 3883.0
|
4~8周 |
科威 |
Cimaterol-d7
|
K028193-10mg
|
分析标准试剂 |
1228182-44-2 |
10mg
|
¥ 4877.0
|
4~8周 |
科威 |
Selexipag-d7
|
S646930-1mg
|
|
1265295-21-3 |
1mg
|
¥ 6900.9
|
期货,请咨询 |
阿拉丁 |
Metolazone-d7
|
M648300-10mg
|
≥99% |
2714484-71-4 |
10mg
|
¥ 16000.9
|
期货,请咨询 |
阿拉丁 |
Molnupiravir-d7
|
M658757-5mg
|
≥99% |
N/A |
5mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
Methylprednisolone-d7
|
M659293-1mg
|
≥99% |
N/A |
1mg
|
¥ 18800.9
|
期货,请咨询 |
阿拉丁 |
Celecoxib-d7
|
R123789-1mg
|
98% |
544686-21-7 |
1mg
|
¥ 2699.0
|
5~7个工作日 |
罗恩 |
prenalterol-d7
|
P343023-2.5mg
|
Moligand™ |
57526-81-5 |
2.5mg
|
¥ 2092.9
|
期货,请咨询 |
阿拉丁 |
Tolvaptan-d7
|
T649308-1mg
|
|
1246818-18-7 |
1mg
|
¥ 1550.9
|
期货,请咨询 |
阿拉丁 |
Ceritinib-d7
|
C650929-1mg
|
|
1632484-77-5 |
1mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Duloxetine-d7
|
D648475-1mg
|
|
919514-01-5 |
1mg
|
¥ 3850.9
|
期货,请咨询 |
阿拉丁 |
匹莫齐特-d4
|
P658709-1mg
|
Moligand™, ≥95 atom% D,≥95% |
N/A |
1mg
|
¥ 2599.9
|
期货,请咨询 |
阿拉丁 |
(3,3-二氟-2-氧庚基)膦酸二甲酯-d7
|
D350011-1mg
|
|
1346601-73-7 |
1mg
|
¥ 2092.9
|
期货,请咨询 |
阿拉丁 |
度洛西汀-D7
|
PCL-#-2024DD434-1mg
|
≥98% |
919514-01-5 |
1mg
|
咨询
|
现货 |
PCL |
脱氧皮质酮-D7
|
pcl-#-DD701-1mg
|
≥98% |
64-85-7(unlabelled) |
1mg
|
咨询
|
现货 |
PCL |
米诺环素-D7
|
PCL-#-2024DD605-1mg
|
≥98% |
N/A |
1mg
|
咨询
|
现货 |
PCL |
利福布汀-D7
|
PCL-#-2024DD439-1mg
|
≥98% |
72559-06-9 |
1mg
|
咨询
|
现货 |
PCL |
度洛西汀-D7
|
PCL-#-2024DD459-1mg
|
≥98% |
919514-01-5 |
1mg
|
咨询
|
现货 |
PCL |
n-Octyl-d17-β-D-Glucopyranoside-d7
|
K021646-100mg
|
97% |
869666-57-9 |
100mg
|
¥ 14944.0
|
4~8周 |
科威 |
n-Octyl-d17-β-D-Glucopyranoside-d7
|
R021646-100mg
|
97% |
869666-57-9 |
100mg
|
¥ 14944.0
|
5~7个工作日 |
罗恩 |
n-Octyl-d17-β-D-Glucopyranoside-d7
|
R021646-500mg
|
97% |
869666-57-9 |
500mg
|
¥ 65290.0
|
5~7个工作日 |
罗恩 |